Mineffect Cold Remedy

Calcarea Flourica, Ferrum Metallicum, Ferrum Phosphoricum, Phosphorus, Silicea, Sulphur, Zincum Metallicum

Kadesh Incoporation Co,ltd
Human Otc Drug
NDC 81488-009

Mineffect Cold Remedy also known as Calcarea Flourica, Ferrum Metallicum, Ferrum Phosphoricum, Phosphorus, Silicea, Sulphur, Zincum Metallicum is a human otc drug labeled by 'Kadesh Incoporation Co,ltd'. National Drug Code (NDC) number for Mineffect Cold Remedy is 81488-009. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Mineffect Cold Remedy drug includes Calcium Fluoride - 6 [hp_X]/30mL Ferrosoferric Phosphate - 7 [hp_X]/30mL Iron - 7 [hp_X]/30mL Phosphorus - 6 [hp_X]/30mL Silicon Dioxide - 4 [hp_X]/30mL Sulfur - 4 [hp_X]/30mL Zinc - 8 [hp_X]/30mL . The currest status of Mineffect Cold Remedy drug is Active.

Drug Information:

Drug NDC:	81488-009
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Mineffect Cold Remedy
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Calcarea Flourica, Ferrum Metallicum, Ferrum Phosphoricum, Phosphorus, Silicea, Sulphur, Zincum Metallicum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Kadesh Incoporation Co,ltd
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	CALCIUM FLUORIDE - 6 [hp_X]/30mL FERROSOFERRIC PHOSPHATE - 7 [hp_X]/30mL IRON - 7 [hp_X]/30mL PHOSPHORUS - 6 [hp_X]/30mL SILICON DIOXIDE - 4 [hp_X]/30mL SULFUR - 4 [hp_X]/30mL ZINC - 8 [hp_X]/30mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	21 Jan, 2022
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	09 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Kadesh Incoporation Co,Ltd
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	O3B55K4YKI 91GQH8I5F7 E1UOL152H7 27YLU75U4W ETJ7Z6XBU4 70FD1KFU70 J41CSQ7QDS
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
81488-009-01	1 BOTTLE in 1 BOX (81488-009-01) / 30 mL in 1 BOTTLE	21 Jan, 2022	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Mineffect Cold Remedy

Calcarea Flourica & more..

Liquid
Kadesh Incoporation Co,Ltd
NDC: 81488-009

Purpose:

Purpose throat pain cough, sneezing cough, sore chest sore throat cough, sore throat sore throat muscus, runny nose the letters hpus indicate that this ingredients is officially included in the homeopathic pharmacopoeia of the united states.

Product Elements:

Mineffect cold remedy calcarea flourica, ferrum metallicum, ferrum phosphoricum, phosphorus, silicea, sulphur, zincum metallicum calcium fluoride fluoride ion iron iron ferrosoferric phosphate ferrosoferric phosphate phosphorus phosphorus silicon dioxide silicon dioxide sulfur sulfur zinc zinc water aluminum oxide kaolin cerous oxalate nonahydrate potassium silicate magnesium chloride magnesium sulfate heptahydrate sodium nitrate

Indications and Usage:

Uses â¢ reduces the duration and severity of common cold symptoms â¢ temporarily relieves symptoms of common cold such as sneezing, cough, sore throat, and runny nose.

Warnings:

Warning do not use *if the tamper resistant label is broken. consult a physician if: â¢ symptoms persist for more than 7 days or worsen. â¢ inflammation, fever, or infection develops. when using this product *to avoid contamination, do not touch tip of container to any surface. replace cap after using. if pregnant or breast-feeding , ask a health professional before use keep out of reach of children

Dosage and Administration:

Direction take 30ml every 6 hours while the cold symptoms persist.

Package Label Principal Display Panel:

Packaging mineffect-009

Further Questions:

Questions or comments? 1-844-kadesh1 mon-fri 9am - 6pm (pst) www.puriton.us 201, eonju-ro, gangnam-gu, seoul south korea 06274

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.